Results 221 to 230 of about 83,737 (309)

Laparoscopic Modified One Anastomosis Gastric Bypass for Severe Obesity After Pancreaticoduodenectomy: A Safe Approach to the Hostile Abdomen, a First Case Report

The Kaohsiung Journal of Medical Sciences, EarlyView.
Chih‐Kun Huang, Ming‐Che Hsin, Long‐Bin Jeng, Ting‐Wei Chang   +3 more
wiley   +1 more source

Neo‐Taphonomic Analysis of Prey Bone Remains Accumulated by Golden Eagle (Aquila chrysaetos): A Case of Nests in Southern France

International Journal of Osteoarchaeology, EarlyView.
ABSTRACT The golden eagle (Aquila chrysaetos) nests in rock cavities where it accumulates prey bone remains during the breeding season. Because nests can be reoccupied from year to year, these faunal elements can form remarkable bone accumulations and, in the sub‐fossil record, be mixed with assemblages derived from human or other predator activities ...
Juliette Ripond, Véronique Laroulandie, Jean‐Baptiste Mallye, Renaud Nadal, Patrick Bayle, Christian Itty   +5 more
wiley   +1 more source

GASTRIC EMPTYING IN PREGNANCY

British Journal of Anaesthesia, 1988
openaire   +2 more sources

What Are the Impacts of GLP‐1 Drugs in Patients Needing Head/Neck Surgery?

The Laryngoscope, EarlyView.
Chelsea Gelboin‐Burkhart, Liam Gallagher, Bridget Ebert, Samir S. Khariwala   +3 more
wiley   +1 more source

Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective This meta‐analysis evaluates the safety and efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) for the treatment of older adults with obesity compared to younger individuals. Methods A systematic review was conducted following PRISMA guidelines (PROSPERO CRD420251074381).
Inês Rego de Figueiredo, Filipa Sofia Simas, Angela Ghiletchi, João Oliveira Torres, José Silva‐Nunes   +4 more
wiley   +1 more source

Non-invasive fluorescence sensing reveals changes in intestinal barrier function and gastric emptying rate in a first-in-human study of Crohn's disease. [PDF]

Ther Adv Gastroenterol
Gan J, Chen Q, Monfort Sanchez E, Mandal N, Xu J, Wang Z, Agarwal A, Oluwatunmise E, Ramkumar P, Salam A, Chekmeneva E, Gómez-Romero M, Maslen L, Balarajah S, Perry R, Yong KK, Hoare J, Powell N, Alexander J, Avery J, Ashrafian H, Darzi A, Thompson AJ.   +22 more
europepmc   +1 more source

Levodopa Efficacy and GLP‐1 Receptor Agonists

Movement Disorders Clinical Practice, EarlyView.
Catherine Martinez, Christine Girges, Thomas Foltynie, Anne‐Marie Wills   +3 more
wiley   +1 more source

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata   +3 more
wiley   +1 more source

Gastric emptying after distal gastrectomy from physiologic viewpoint: accelerated or delayed? [PDF]

J Smooth Muscle Res
Shibata C, Sawada K, Mitamura A, Nakano T.   +3 more
europepmc   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source